# Eshelman Ventures: portfolio, investments and team > Eshelman Ventures is a vc firm based in United States. 5 investments on record, latest Dec 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/eshelman-ventures (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Eshelman Ventures Last cheque observed Dec 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet VC firm Seed Series A Series B Wellbeing Healthier Living Well-being Cheques on record **0%** of best year **0** **cheques in 12 months**, 5 on record Since the last cheque **2504** days **00** hrs **00** min **00** sec Median round **$44M** Rounds led **0 of 5** Sole investor **2 rounds** Mostly in **United States, 100%** Pitch Eshelman Ventures ## Eshelman Ventures highlights - 01 5 rounds on record - 02 Mostly Series B and Series D: 75% of its rounds - 03 Sole investor in 2 rounds, median $21M ## What they do - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth - **Sectors:** Wellbeing Healthier Living Well-being - **Based in:** Wilmington, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **5 appearances** - **2019** 2 rounds - **Dec** **[Kinnate Biopharma](https://millionrounds.com/company/kinnate-biopharma)** Series B · US · FinSMEs **$75M** With 4 others - **Jul** **[ArunA Bio](https://millionrounds.com/company/aruna-bio)** US · FinSMEs **$13M** Sole investor - **2015** 3 rounds - **Apr** **[Innocrin Pharmaceuticals](https://millionrounds.com/company/innocrin-pharmaceuticals)** Series D · US **$28M** Sole investor - **Feb** **[G1 Therapeutics, Inc.](https://millionrounds.com/company/g1-therapeutics-inc)** Series B · US **$33M** With 5 others - **Feb** **[Dignify Therapeutics](https://millionrounds.com/company/dignify-therapeutics)** Venture · US **$3.0M** With 2 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What they claim to have backed From their own portfolio page (on their website) **6** of 13 we have independently watched raise [Aruna Bio](https://millionrounds.com/company/aruna-bio)[Cavalry](https://millionrounds.com/company/cavalry)[Dignify Therapeutics](https://millionrounds.com/company/dignify-therapeutics)[Jupiter Bioventures](https://millionrounds.com/company/jupiter-bioventures)[Paradigm Therapeutics](https://millionrounds.com/company/paradigm-therapeutics)[Sapience Therapeutics](https://millionrounds.com/company/sapience-therapeutics) Breakthru Medicine Carbon Genesis KOMO Biosciences Med Aditus Phoenix Molecular Designs Wilmingtondesignco Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## The cheque Seed Series A Series B Median round joined **$44M** the round, not its cheque Alone, median **$21M** Led 0 of 5 rounds **0%** - **Sole investor:** 2 rounds - **Last cheque:** Dec 2019 Rounds by stage said on their site - Series B said *2* - Series D *1* - Venture *1* - Seed said *-* - Series A said *-* - Growth said *-* Cheques by year Led Joined 2015 2019 Often in the room with - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 2 **Pitching Eshelman Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Eshelman Ventures. A count of rooms they were both in, not a relationship either has claimed. [**RA Capital Management** Private equity **2** rounds together](https://millionrounds.com/fund/ra-capital-management) ## Quick answers about Eshelman Ventures ### What does Eshelman Ventures invest in? Eshelman Ventures invests most often at Series B and Series D (75% of the rounds on record), in sectors such as Wellbeing, Healthier Living and Well-being. ### How active is Eshelman Ventures? 5 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2019. ### What has Eshelman Ventures invested in recently? Its most recent investments on record: Kinnate Biopharma (Series B, Dec 2019) and ArunA Bio (Undisclosed round, Jul 2019). ### How big are Eshelman Ventures's cheques? The median round it joins is $44M. ### Does Eshelman Ventures lead rounds? Rarely, if at all: none of its 5 investments on record names it as the lead. ### Where does Eshelman Ventures invest? Most of the companies it backs are in the United States (100%). ### Is Eshelman Ventures investing now? No investments in the last 12 months; the latest was in Dec 2019. ### Who does Eshelman Ventures invest alongside? Most often RA Capital Management (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=eshelman-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=eshelman-ventures)